The future of cellular therapy for the treatment of renal cell carcinoma

Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors

A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma

Autologous Dendritic Vaccine Therapy in Metastatic Kidney Cancer: The ADAPT Trial and Beyond

Novel immunotherapy combinations for genitourinary cancers

New treatment modalities with vaccine therapy in renal cell carcinoma

Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses

Current status of clinical trials assessing oncolytic virus therapy for urological cancers

Immunomonitoring reveals interruption of anergy after vaccination in a case of type-2-papillary renal cell carcinoma

Recent advances in immuno-oncology and its application to urological cancers